Profile | GDS5420 / 205473_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 68.42 | 36 |
GSM1296119 | B_lesional_pre-dose | 129.66 | 44 |
GSM1296076 | C_lesional_pre-dose | 28.96 | 22 |
GSM1296092 | D_lesional_pre-dose | 152.89 | 50 |
GSM1296103 | E_lesional_pre-dose | 149.21 | 48 |
GSM1296078 | F_lesional_pre-dose | ||
GSM1296107 | G_lesional_pre-dose | 81.69 | 36 |
GSM1296109 | H_lesional_pre-dose | 63.13 | 32 |
GSM1296080 | I_lesional_pre-dose | 169.46 | 51 |
GSM1296090 | J_lesional_pre-dose | 123.71 | 46 |
GSM1296074 | K_lesional_pre-dose | 38.9 | 29 |
GSM1296111 | L_lesional_pre-dose | 51.91 | 28 |
GSM1296099 | M_lesional_pre-dose | 158.72 | 48 |
GSM1296086 | O_lesional_pre-dose | 82.12 | 40 |
GSM1296117 | P_lesional_pre-dose | 63.59 | 32 |
GSM1296113 | Q_lesional_pre-dose | 35.18 | 20 |
GSM1296096 | R_lesional_pre-dose | 147.48 | 48 |
GSM1296105 | S_lesional_pre-dose | 512.48 | 68 |
GSM1296098 | T_lesional_pre-dose | 30.43 | 20 |
GSM1296101 | U_lesional_pre-dose | 113.46 | 43 |
GSM1296121 | V_lesional_pre-dose | ||
GSM1296088 | W_lesional_pre-dose | 28.37 | 24 |
GSM1296082 | X_lesional_pre-dose | ||
GSM1296115 | Y_lesional_pre-dose | 88.83 | 38 |
GSM1296084 | Z_lesional_pre-dose | 114.55 | 44 |
GSM1296072 | B_lesional_day8 | 98.57 | 40 |
GSM1296069 | L_lesional_day8 | 77.69 | 34 |
GSM1296071 | P_lesional_day8 | 144.11 | 44 |
GSM1296070 | Y_lesional_day8 | 172.81 | 48 |
GSM1296073 | V_lesional_day8 | ||
GSM1296034 | A_lesional_day15 | 402.47 | 63 |
GSM1296041 | G_lesional_day15 | ||
GSM1296035 | R_lesional_day15 | 42.59 | 30 |
GSM1296038 | U_lesional_day15 | 66.87 | 35 |
GSM1296047 | B_lesional_day15 | 209.87 | 52 |
GSM1296039 | E_lesional_day15 | ||
GSM1296042 | H_lesional_day15 | 25.08 | 18 |
GSM1296043 | L_lesional_day15 | 82.57 | 35 |
GSM1296037 | M_lesional_day15 | 964.27 | 79 |
GSM1296046 | P_lesional_day15 | 256.05 | 55 |
GSM1296044 | Q_lesional_day15 | 146.97 | 45 |
GSM1296045 | Y_lesional_day15 | 241.8 | 54 |
GSM1296025 | C_lesional_day15 | 343.85 | 62 |
GSM1296033 | D_lesional_day15 | 118.35 | 44 |
GSM1296027 | I_lesional_day15 | 338.9 | 62 |
GSM1296032 | J_lesional_day15 | 634.94 | 71 |
GSM1296024 | K_lesional_day15 | 376.14 | 63 |
GSM1296031 | W_lesional_day15 | 214.64 | 53 |
GSM1296028 | X_lesional_day15 | 283.57 | 58 |
GSM1296029 | Z_lesional_day15 | 167.75 | 50 |
GSM1296026 | F_lesional_day15 | 19.93 | 17 |
GSM1296030 | O_lesional_day15 | 176.55 | 52 |
GSM1296040 | S_lesional_day15 | 175.05 | 50 |
GSM1296036 | T_lesional_day15 | 70.08 | 35 |
GSM1296048 | V_lesional_day15 | 2.51 | 2 |
GSM1296059 | A_lesional_day43 | 114.44 | 44 |
GSM1296066 | G_lesional_day43 | 84.75 | 36 |
GSM1296060 | R_lesional_day43 | 189.29 | 51 |
GSM1296063 | U_lesional_day43 | 51.71 | 31 |
GSM1296064 | E_lesional_day43 | 47.87 | 31 |
GSM1296067 | H_lesional_day43 | 64.71 | 32 |
GSM1296062 | M_lesional_day43 | 447.42 | 65 |
GSM1296068 | Q_lesional_day43 | 200.95 | 50 |
GSM1296050 | C_lesional_day43 | 175.71 | 50 |
GSM1296057 | D_lesional_day43 | 398.78 | 63 |
GSM1296052 | I_lesional_day43 | 379.6 | 64 |
GSM1296054 | J_lesional_day43 | 506.54 | 67 |
GSM1296049 | K_lesional_day43 | 232.29 | 55 |
GSM1296055 | W_lesional_day43 | 129.56 | 44 |
GSM1296053 | X_lesional_day43 | 365.76 | 62 |
GSM1296058 | Z_lesional_day43 | 284.85 | 58 |
GSM1296051 | F_lesional_day43 | 29.67 | 23 |
GSM1296056 | O_lesional_day43 | 77.79 | 39 |
GSM1296065 | S_lesional_day43 | 146.58 | 47 |
GSM1296061 | T_lesional_day43 | 16.36 | 14 |
GSM1296095 | A_non-lesional_pre-dose | 28.66 | 24 |
GSM1296120 | B_non-lesional_pre-dose | 377.56 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 266.85 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 877.6 | 77 |
GSM1296104 | E_non-lesional_pre-dose | 322.24 | 60 |
GSM1296079 | F_non-lesional_pre-dose | 327.25 | 61 |
GSM1296108 | G_non-lesional_pre-dose | 89.3 | 38 |
GSM1296110 | H_non-lesional_pre-dose | 102.54 | 39 |
GSM1296081 | I_non-lesional_pre-dose | 1301.89 | 83 |
GSM1296091 | J_non-lesional_pre-dose | 485.88 | 67 |
GSM1296075 | K_non-lesional_pre-dose | 33.09 | 25 |
GSM1296112 | L_non-lesional_pre-dose | 292.83 | 57 |
GSM1296100 | M_non-lesional_pre-dose | 1496.28 | 86 |
GSM1296087 | O_non-lesional_pre-dose | 347.14 | 63 |
GSM1296118 | P_non-lesional_pre-dose | 755.77 | 75 |
GSM1296114 | Q_non-lesional_pre-dose | 178.37 | 49 |
GSM1296097 | R_non-lesional_pre-dose | 285.02 | 58 |
GSM1296106 | S_non-lesional_pre-dose | 342.93 | 60 |
GSM1296102 | U_non-lesional_pre-dose | 294.57 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 185.76 | 50 |
GSM1296089 | W_non-lesional_pre-dose | 170.59 | 49 |
GSM1296083 | X_non-lesional_pre-dose | 453.9 | 66 |
GSM1296116 | Y_non-lesional_pre-dose | 216.14 | 52 |
GSM1296085 | Z_non-lesional_pre-dose | 797.9 | 75 |